Boyu Capital Group Holdings Ltd - Net Worth and Insider Trading
Boyu Capital Group Holdings Ltd Net Worth
The estimated net worth of Boyu Capital Group Holdings Ltd is at least $568 Million dollars as of 2024-06-22. Boyu Capital Group Holdings Ltd is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics and owns about 82,979,730 shares of Ocumension Therapeutics (HKSE:01477) stock worth over $568 Million. Details can be seen in Boyu Capital Group Holdings Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Boyu Capital Group Holdings Ltd has not made any transactions after 2023-12-01 and currently still holds the listed stock(s).
Transaction Summary of Boyu Capital Group Holdings Ltd
Boyu Capital Group Holdings Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Boyu Capital Group Holdings Ltd owns 1 companies in total, including Ocumension Therapeutics (HKSE:01477) .
Click here to see the complete history of Boyu Capital Group Holdings Ltd’s form 4 insider trades.
Insider Ownership Summary of Boyu Capital Group Holdings Ltd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2023-12-01 | 2201 Interest of corporation controlled by you |
Boyu Capital Group Holdings Ltd Latest Holdings Summary
Boyu Capital Group Holdings Ltd currently owns a total of 1 stock. Boyu Capital Group Holdings Ltd owns 82,979,730 shares of Ocumension Therapeutics (HKSE:01477) as of December 1, 2023, with a value of $568 Million.
Latest Holdings of Boyu Capital Group Holdings Ltd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01477 | Ocumension Therapeutics | 2023-12-01 | 82,979,730 | 6.84 | 567,581,353 |
Holding Weightings of Boyu Capital Group Holdings Ltd
Boyu Capital Group Holdings Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Boyu Capital Group Holdings Ltd has made a total of 3 transactions in Ocumension Therapeutics (HKSE:01477) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ocumension Therapeutics is the acquisition of 150,000 shares on December 1, 2023, which cost Boyu Capital Group Holdings Ltd around $1 Million.
Insider Trading History of Boyu Capital Group Holdings Ltd
- 1
Boyu Capital Group Holdings Ltd Trading Performance
GuruFocus tracks the stock performance after each of Boyu Capital Group Holdings Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Boyu Capital Group Holdings Ltd is -25.62%. GuruFocus also compares Boyu Capital Group Holdings Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Boyu Capital Group Holdings Ltd within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Boyu Capital Group Holdings Ltd's insider trading performs compared to the benchmark.
Performance of Boyu Capital Group Holdings Ltd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.77 |  | | | | |
| Relative Return to S&P 500(%) | -6.58 | | | | | |
Boyu Capital Group Holdings Ltd Ownership Network
Boyu Capital Group Holdings Ltd Owned Company Details
What does Ocumension Therapeutics do?
Who are the key executives at Ocumension Therapeutics?
Boyu Capital Group Holdings Ltd is the 2201 Interest of corporation controlled by you of Ocumension Therapeutics. Other key executives at Ocumension Therapeutics include 2201 Interest of corporation controlled by you Temasek Holdings (private) Limited , 2101 Beneficial owner Liu Ye , and 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. .
Ocumension Therapeutics (HKSE:01477) Insider Trades Summary
Over the past 18 months, Boyu Capital Group Holdings Ltd made 2 insider transaction in Ocumension Therapeutics (HKSE:01477) with a net purchase of 150,000. Other recent insider transactions involving Ocumension Therapeutics (HKSE:01477) include a net sale of 500 shares made by Liu Ye , a net sale of 3,800,000 shares made by Temasek Holdings (private) Limited , and a net sale of 427,000 shares made by The Capital Group Companies, Inc. .
In summary, during the past 3 months, insiders sold 1,500,000 shares of Ocumension Therapeutics (HKSE:01477) in total and bought 0 shares, with a net sale of 1,500,000 shares. During the past 18 months, 4,227,500 shares of Ocumension Therapeutics (HKSE:01477) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 4,077,500 shares.
Ocumension Therapeutics (HKSE:01477)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ocumension Therapeutics Insider Transactions
Boyu Capital Group Holdings Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Boyu Capital Group Holdings Ltd. Currently GuruFocus does not have mailing address information for Boyu Capital Group Holdings Ltd.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
